Completed NA INTERVENTIONAL 4-arm NCT02889224

In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man (VISECA)

Sponsor: University Hospital, Bordeaux

Interventions Control Hydrocortisone Hypercortisolism Obese

Updated 5 times since 2017 Last updated: Oct 11, 2018 Started: Feb 29, 2012 Primary completion: Sep 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02889224, this NA trial focuses on Cushing's Syndrome and remains completed. Sponsored by University Hospital, Bordeaux, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Nov 2018 [monthly]

Completed NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Bordeaux

Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pessac, France